Long-term vaccination strategies to mitigate the impact of SARS-CoV-2 transmission: A modelling study
by Alexandra B. Hogan, Sean L. Wu, Jaspreet Toor, Daniela Olivera Mesa, Patrick Doohan, Oliver J. Watson, Peter Winskill, Giovanni Charles, Gregory Barnsley, Eleanor M. Riley, David S. Khoury, Neil M. Ferguson, Azra C. Ghani
Background
Vaccines have reduced severe disease and death from Coronavirus Disease 2019 (COVID-19). However, with evidence of waning efficacy coupled with continued evolution of the virus, health programmes need to evaluate the requirement for regular booster doses, considering their impact and cost-effectiveness in the face of ongoing transmission and substantial infection-induced immunity.
Methods and findings
We developed a combined immunological-transmission model parameterised with data on transmissibility, severity, and vaccine effectiveness. We simulated Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) transmission and vaccine rollout in characteristic global settings with different population age-structures, contact patterns, health system capacities, prior transmission, and vaccine uptake. We quantified the impact of future vaccine booster dose strategies with both ancestral and variant-adapted vaccine products, while considering the potential future emergence of new variants with modified transmission, immune escape, and severity properties. We found that regular boosting of the oldest age group (75+) is an efficient strategy, although large numbers of hospitalisations and deaths could be averted by extending vaccination to younger age groups. In countries with low vaccine coverage andhigh infection-derived immunity, boosting older at-risk groups was more effective than continuing primary vaccination into younger ages in our model. Our study is limited by uncertainty in key parameters, including the long-term durability of vaccine and infection-induced immunity as well as uncertainty in the future evolution of the virus.
Conclusions
Our modelling suggests that regular boosting of the high-risk population remains an important tool to reduce morbidity and mortality from current and future SARS-CoV-2 variants. Our results suggest that focusing vaccination in the highest-risk cohorts will be the most efficient (and hence cost-effective) strategy to reduce morbidity and mortality.
Our "Network":Project Gutenberg
https://gutenberg.classicistranieri.com
EncyclopaediaBritannica1911
https://encyclopaediabritannica.classicistranieri.com
Librivox Audiobooks
https://librivox.classicistranieri.com
Linux Distributions
https://old.classicistranieri.com
Magnatune (MP3 Music)
https://magnatune.classicistranieri.com
Static Wikipedia (June 2008)
https://wikipedia.classicistranieri.com
Static Wikipedia (March 2008)
https://wikipedia2007.classicistranieri.com/mar2008/
Static Wikipedia (2007)
https://wikipedia2007.classicistranieri.com
Static Wikipedia (2006)
https://wikipedia2006.classicistranieri.com
Liber Liber
https://liberliber.classicistranieri.com
ZIM Files for Kiwix
https://zim.classicistranieri.com
Other Websites:
Bach - Goldberg Variations
https://www.goldbergvariations.org
Lazarillo de Tormes
https://www.lazarillodetormes.org
Madame Bovary
https://www.madamebovary.org
Il FuMattiaPascal
https://www.mattiapascal.it
The Voice in the Desert
https://www.thevoiceinthedesert.org
Confessione d'un amorefascista
https://www.amorefascista.it
Malinverno
https://www.malinverno.org
Debito formativo
https://www.debitoformativo.it
Adina Spire
https://www.adinaspire.com